Thursday, 29 October 20266:58 am ISTIndia edition

Just in

5:42 amKarnataka SIR: 64.5 lakh voters potentially missing in rolls, majority of them young
5:18 amPoland pivots towards India as ‘strategic partnership’ with China develops cracks
5:12 amBihar Cabinet approves MOU between WRD & NIH, Roorkee for ‘Flood Plain Zone Delineation Study’
3:42 amLiverpool 1-1 (6-5 p/k) Chelsea, League Cup: Post-match reaction, ratings
3:24 amOil prices rise as Houthi attack on Saudi refinery stokes supply disruption fears
SponsoredPut your announcement in this ticker from ₹69/day
3:05 amForest panel rejects Uttarakhand HC relocation plan again over forest land concerns
2:53 amNCP leader challenges Sunetra Pawar’s decision to appoint a new national chief spokesperson
2:40 amFlávio Bolsonaro declares himself Brazil’s ‘true president’, vows to lead opposition from US
2:32 amCorporation councillor willing to express regret for abusing and body shaming Chief Minister C. Joseph Vijay, her counsel tells Madras High Court
2:29 amStock Market Today: Alphabet, Microsoft Earnings in Focus; Fed Holds Rates — Live Updates
2:19 amBihar MLC polls: Upper caste candidates dominate election results
2:11 amRailways to turn off charging points in trains during night
2:10 amCapturing Complete Process Of Embryonic Development
2:03 amAll 17 escapees from Theni district jail apprehended in less than 40 hours: IGP South Zone
5:42 amKarnataka SIR: 64.5 lakh voters potentially missing in rolls, majority of them young
5:18 amPoland pivots towards India as ‘strategic partnership’ with China develops cracks
5:12 amBihar Cabinet approves MOU between WRD & NIH, Roorkee for ‘Flood Plain Zone Delineation Study’
3:42 amLiverpool 1-1 (6-5 p/k) Chelsea, League Cup: Post-match reaction, ratings
3:24 amOil prices rise as Houthi attack on Saudi refinery stokes supply disruption fears
SponsoredPut your announcement in this ticker from ₹69/day
3:05 amForest panel rejects Uttarakhand HC relocation plan again over forest land concerns
2:53 amNCP leader challenges Sunetra Pawar’s decision to appoint a new national chief spokesperson
2:40 amFlávio Bolsonaro declares himself Brazil’s ‘true president’, vows to lead opposition from US
2:32 amCorporation councillor willing to express regret for abusing and body shaming Chief Minister C. Joseph Vijay, her counsel tells Madras High Court
2:29 amStock Market Today: Alphabet, Microsoft Earnings in Focus; Fed Holds Rates — Live Updates
2:19 amBihar MLC polls: Upper caste candidates dominate election results
2:11 amRailways to turn off charging points in trains during night
2:10 amCapturing Complete Process Of Embryonic Development
2:03 amAll 17 escapees from Theni district jail apprehended in less than 40 hours: IGP South Zone

Health

First In Vivo Trial for Wilson Disease

Reported by BioTecNika 28 Oct 2026, 5:26 pm IST 1 min read

Image: BioTecNika. Rights remain with the publisher.

Scientists launch the first in vivo prime editing trial for Wilson's disease, treating the first patient as clinical results are awaited.

CRISPR Prime Editing: First In Vivo Trial for Wilson’s Disease For years, scientists have been working on ways to treat genetic disorders that cause serious health problems. Now, a Phase 1/2 clinical trial is testing an experimental prime-editing tre... [6288 chars]

Read the full report on BioTecNika

Story file

Section: Health
First reported by: BioTecNika
Published: Wednesday, 28 October 2026, 5:26 pm IST
Coverage: One outlet so far

How this page works. The Headline Update lists this report from BioTecNika with a short summary and a link to the original. The original reporting and photograph belong to the publisher. Spotted an error in our summary? Tell our corrections desk.